探花合集 Wins Prestigious CPhI Pharma Award at CPhI Worldwide
探花合集鈥檚 OptiForm Solution Suite is an integrated service designed for early stage small molecules, using a unique toolkit of formulation technologies and expertise. It incorporates comprehensive molecule characterization and parallel evaluation of four formulation technologies, including salt form optimization, lipid formulation, solid dispersion and particle size reduction. OptiForm Solution Suite matches the best formulation technologies to each molecule, and uses an accelerated parallel screening and development protocol, based on rigorous science and best-in-class scientific expertise, to provide in vivo study material in 12 weeks, including two weeks鈥 stability data.
To expand the service to the early phase development of peptides and macromolecules, OptiForm Solution Suite Bio was launched to rapidly screen biomolecules鈥 potential for non-invasive, oral delivery. It employs two proven formulation technologies, OptiGel鈩 Bio and Zydis庐 Bio, and uses a parallel screening model to deliver in vivo study material within three weeks.
鈥淲e are delighted that the OptiForm Solution Suite platform has won further industry recognition, having won the 鈥楨ditor鈥檚 Choice鈥 category at the annual INTERPHEX awards earlier this year,鈥 commented Julien Meissonnier, 探花合集鈥檚 Vice President, Science & Technology. He added, 鈥淥ptiForm Solution Suite offers easy, simple, fast and cost effective approaches for both small and macromolecules in early development phases. Our recent acquisition of Pharmatek will add their extensive early-phase drug development capabilities, and pharmaceutical spray dry expertise as a further option to overcome bioavailability issues.鈥
Established in 2004, the CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. The awards celebrate thinkers and creators breaking new ground and strongly advocates companies committed to driving the industry forward.
For further information or to arrange a meeting with a member of the executive team during the show, please contact Richard Kerns at NEPR ([email protected]).
About 探花合集
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs approximately 9,200 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit .